Results 261 to 270 of about 591,365 (304)
Some of the next articles are maybe not open access.

MYOCARDITIS AND DILATED CARDIOMYOPATHY

Annual Review of Medicine, 1987
The recent developments in the study of myocarditis and dilated cardiomyopathy are reviewed here, with the primary emphasis on the issue of myocarditis as a precursor to dilated cardiomyopathy. Advances in immunologic approaches have expanded our knowledge of the course of myocarditis, experimentally as well as clinically.
C, Kawai, A, Matsumori, H, Fujiwara
openaire   +2 more sources

Immunopathogenesis of dilated cardiomyopathies

Current Opinion in Cardiology, 1995
Idiopathic dilated cardiomyopathy is a chronic heart muscle disorder of unknown etiology, but experimental and clinical evidence is accumulating that points to an immune pathogenesis in a subset of patients, and to the potential importance of myosin as an antigen. Most recent developments include evidence of cardiac- and disease-specific autoantibodies
J H, Goldman, W J, McKenna
openaire   +2 more sources

Dilated cardiomyopathy

Current Treatment Options in Cardiovascular Medicine, 2001
The management of patients with dilated cardiomyopathy (DCM) heart failure starts with the determination of the underlying diagnosis, definition of the hemodynamic character (eg, systolic, diastolic, valvular, right- and left-sided heart dysfunction), recognition of complicating factors (eg, atrial fibrillation, renal dysfunction), and consideration ...
openaire   +2 more sources

Dilated cardiomyopathy

European Heart Journal, 1984
On account of the rapidly progressive nature of the disease, the high incidence of systemic embolism and arrhythmias, and the risk of sudden death, dilated cardiomyopathy is inconsistent with aircrew duties. In the small proportion of subjects who apparently make a satisfactory recovery , re-licensing may be considered once there is no requirement for ...
openaire   +2 more sources

Anaphylatoxins in dilated cardiomyopathy

Journal of Internal Medicine, 1993
Abstract. Objects. The aim of the study was to investigate the possible relationship between activation of complement system and thromboembolic complications in dilated cardiomyopathy (DCMP).Methods. The plasma C3a and C5a concentrations were determined by radioimmunoassay measurement (Amersham International, UK) in 23 patients with DCMP, 9 with ...
M, Samsonov   +5 more
openaire   +2 more sources

Genetics of Dilated Cardiomyopathy

Heart Failure Clinics, 2010
Dilated cardiomyopathy (DCM) is a myocardial disorder defined by ventricular chamber enlargement and systolic dysfunction. DCM can result in progressive heart failure, arrhythmias, thromboembolism, and premature death, and contributes significantly to health care costs. In many cases, DCM results from acquired factors that affect cardiomyocyte function
Diane, Fatkin   +2 more
openaire   +2 more sources

Living with dilated cardiomyopathy

BMJ, 2016
Richard Mindham has been living with the diagnosed condition for nine years and shares his experiences as a ...
openaire   +2 more sources

Familial dilated cardiomyopathy

American Journal of Medical Genetics, 1988
AbstractIdiopathic dilated cardiomyopathy is generally considered a sporadic, nongenetic disorder, and reports of familial cases are often regarded as rare occurrences. Results of the present investigation of 6 families with this disorder suggest that familial forms of dilated cardiomyopathy occur more frequently than previously suspected. The familial
Michael A. Schmidt   +5 more
openaire   +2 more sources

Genetics of Dilated Cardiomyopathy

Current Cardiology Reports, 2018
Dilated cardiomyopathy (DCM) is characterized by left ventricular dilation and systolic function and is the most common among all cardiomyopathies. Familial DCM makes up a significant portion of cases, and approximately 40 genes are identified as involved in the pathogenesis of heart failure, each affecting a specific part of cellular mechanisms.
Yiwen, Fu, Howard J, Eisen
openaire   +2 more sources

Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy.

Biochemical and Biophysical Research Communications - BBRC, 2018
Mesenchymal stem cells (MSCs) have been shown to be efficacy to attenuating cardiovascular inflammation; however, there are many limitations to stem cell treatment. Present study was to prove MSC-derived exosomes (MSC-Exos) could alleviating inflammatory
Xuan Sun, Anqi Shan, Zilun Wei, Biao Xu
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy